Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for blood products].

G Vezon

    La Revue Du Praticien
    |September 11, 1989
    PubMed
    Summary

    Optimal blood product use requires understanding characteristics and transfusion risks. Diluted albumin is now preferred over fresh frozen plasma, with viral inactivation improving component safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura.

    Platelets·2010
    Same author

    Pathogen inactivation of platelet concentrates.

    Vox sanguinis·2010
    Same author

    [Follicular mucinosis].

    Annales de dermatologie et de venereologie·2004
    Same author

    Variations of factor VIII:C plasma levels with respect to the blood group ABO.

    Transfusion medicine (Oxford, England)·2004
    Same author

    Plateletpheresis concentrates produced with the COMTEC cell separator: the French experience.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2002
    Same author

    [Panniculitis induced by MINE chemotherapy].

    Annales de dermatologie et de venereologie·2001

    Area of Science:

    • Transfusion Medicine
    • Hematology
    • Critical Care

    Context:

    • Established indications for blood product transfusion.
    • Historical context of HIV transmission via blood products since 1982.
    • Evolving transfusion practices in intensive care units.

    Purpose:

    • To review the optimal use of blood products.
    • To highlight the safety of modern blood components.
    • To discuss current preferences in plasma-volume expanders.

    Summary:

    • Optimal blood product utilization necessitates comprehensive knowledge of product attributes and transfusion risks.
    • Shift in practice favors diluted albumin over fresh frozen plasma, except in rare circumstances.
    • Advances in viral inactivation techniques have significantly enhanced the safety of hemostatic blood components against viral transmission.

    Impact:

    • Informed clinical decision-making regarding blood product selection.
    • Reduced risk of transfusion-transmitted infections.
    • Improved patient safety in transfusion medicine.

    Related Experiment Videos